As of 2025-05-16, the EV/EBITDA ratio of Exagen Inc (XGN) is -9.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 112.49 mil USD. XGN's TTM EBITDA according to its financial statements is -12.29 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 10.1x | 9.2x |
| Forward P/E multiples | 7.5x - 9.4x | 8.4x |
| Fair Price | (6.15) - (7.01) | (6.59) |
| Upside | -207.1% - -222.2% | -214.8% |
| Date | EV/EBITDA |
| 2025-05-15 | -9.15 |
| 2025-05-14 | -9.27 |
| 2025-05-13 | -8.99 |
| 2025-05-12 | -9.20 |
| 2025-05-09 | -9.11 |
| 2025-05-08 | -9.76 |
| 2025-05-07 | -10.74 |
| 2025-05-06 | -10.14 |
| 2025-05-05 | -9.89 |
| 2025-05-02 | -9.56 |
| 2025-05-01 | -9.73 |
| 2025-04-30 | -9.87 |
| 2025-04-29 | -10.81 |
| 2025-04-28 | -10.48 |
| 2025-04-25 | -9.84 |
| 2025-04-24 | -9.31 |
| 2025-04-23 | -9.12 |
| 2025-04-22 | -7.84 |
| 2025-04-21 | -7.24 |
| 2025-04-17 | -7.33 |
| 2025-04-16 | -7.30 |
| 2025-04-15 | -7.21 |
| 2025-04-14 | -7.49 |
| 2025-04-11 | -7.00 |
| 2025-04-10 | -6.95 |
| 2025-04-09 | -7.20 |
| 2025-04-08 | -6.62 |
| 2025-04-07 | -6.73 |
| 2025-04-04 | -6.66 |
| 2025-04-03 | -7.01 |
| 2025-04-02 | -7.24 |
| 2025-04-01 | -6.52 |
| 2025-03-31 | -6.02 |
| 2025-03-28 | -6.38 |
| 2025-03-27 | -6.97 |
| 2025-03-26 | -6.98 |
| 2025-03-25 | -6.41 |
| 2025-03-24 | -6.69 |
| 2025-03-21 | -6.44 |
| 2025-03-20 | -6.17 |
| 2025-03-19 | -6.25 |
| 2025-03-18 | -6.06 |
| 2025-03-17 | -6.06 |
| 2025-03-14 | -5.98 |
| 2025-03-13 | -5.67 |
| 2025-03-12 | -5.64 |
| 2025-03-11 | -5.70 |
| 2025-03-10 | -4.94 |
| 2025-03-07 | -5.50 |
| 2025-03-06 | -5.35 |